Sensory function and albumin excretion according to diagnostic criteria for diabetes

Diabetes Care

Volumn 27, Issue 7, 2004, Pages 1716-1720

  Sosenko, Jay M ^a,b   Kato, Martha ^a   Goldberg, Ronald B ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCEPTIVE THRESHOLD; PROTEINURIA; SCREENING TEST; SENSORY STIMULATION; URINALYSIS; URINARY EXCRETION;

ADULT; ALBUMINURIA; BLOOD GLUCOSE; CREATININE; DIABETES MELLITUS; GLUCOSE TOLERANCE TEST; HUMANS; MASS SCREENING; MIDDLE AGED; NEURONS, AFFERENT; REPRODUCIBILITY OF RESULTS;

EID: 3042762512     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.7.1716     Document Type: Article

References (24)

1. LeRoith D: Beta-cell dysfunction and insulin resistance in type 2 diabetes: role of genetic and metabolic abnormalities. Am J Med 113 (Suppl. 6A):35-115, 2002
2. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
3. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
4. Sosenko JM, Kato M, Ramon S, Goldberg RB: Sensory function at diagnosis and in early stages of NIDDM in patients detected through screening. Diabetes Care 15:847-852, 1992
5. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26:3160-3171, 2003
6. de Neeling JND, Beks PJ, Bertelsmann FW, Heine RJ, Bouter LM: Peripheral somatic nerve function in relation to glucose tolerance in an elderly Caucasian population: the Hoorn study. Diabet Med 13:960-966, 1996
7. Ward JD, Barnes CG, Fisher DJ, Jessop JD, Baker RWR: Improvement in nerve conduction following treatment in newly diagnosed diabetics. Lancet 1:428-431, 1971
8. Fraser DM, Campbell IW, Ewing DJ, Murray A, Neilson JMM, Clarke BF: Peripheral and autonomic nerve function in newly diagnosed diabetes mellitus. Diabetes 26: 546-550, 1977
9. Ratzmann KP, Raschke M, Gander I, Schimke E: Prevalence of peripheral and autonomic neuropathy in newly diagnosed type II (noninsulin-dependent) diabetes. J Diabetes Complications 5:1-5, 1991
10. Lehtinen JM, Uusitupa M, Onni S, Pyörälä K: Prevalence of neuropathy in newly diagnosed NIDDM and nondiabetic control subjects. Diabetes 38:1307-1313, 1989
11. Uusitupa M, Siitonen O, Penttila I, Aro A, Pyörälä K: Proteinuria in newly diagnosed type II diabetic patients. Diabetes Care 10: 191-194, 1987
12. Collins VR, Dowse GK, Finch CF, Zimmet PZ, Linnane AW: Prevalence and risk factors for micro- and macroalbuminuria in diabetic subjects and entire population of Nauru. Diabetes 38:1602-1610, 1989
13. Metcalf PA, Baker JR, Scragg RKR, Dryson E, Scott AJ, Wild CJ: Microalbuminuria in a middle-aged workforce. Diabetes Care 16:1485-1493, 1993
14. Niskanen LK, Penttilä I, Parviainen M, Uusitupa MIJ: Evolution, risk factors, and prognostic implications of alburainuria in NIDDM. Diabetes Care 19:486-493, 1996
15. Sosenko JM, Hu D, Welty T, Howard BV, Lee E, Robbins DC: Albuminuria in recent onset type 2 diabetes: the Strong Heart Study. Diabetes Care 25:1078-1084, 2002
16. Mykkanen L, Haffner SM, Kuusisto J, Pyorala K, Laakso M: Microalbuminuria precedes the development of NIDDM. Diabetes 43:552-557, 1994
17. Viberti GC, Pickup RJ, Jarrett RJ, Keen H: Effect of control of blood glucose on urinary excretion of albumin and B2-microglobulin in insulin-dependent diabetes. N Engl J Med 300:639-641, 1979
18. Nelson RG, Bennett PH, Beck GJ, Tan M, Knowler WC, Mitch WE, Hirschman GH, Myers BD: Development and progression of renal disease in Pima Indians with noninsulin-dependent diabetes mellitus: Diabetes Renal Disease Study Group. N Engl J Med 28:335:1636-1642, 1996
19. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
20. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
21. American Diabetes Association: Screening for type 2 diabetes (Position Statement). Diabetes Care 26 (Suppl. 1):S21-S24, 2003
22. American Diabetes Association: Screening for type 2 diabetes (Position Statement). Diabetes Care 27 (Suppl. 1):S11-S14, 2004
23. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group: Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ 317:371-375, 1998
24. Harris MI, Eastman RC: Early detection of undiagnosed diabetes mellitus: a US perspective. Diabetes Metab Res Rev 16:230-236, 2000